Gressy en France, France

Jean-Francois Chantot

This inventor holds 27 USPTO granted patents, primarily in Antibiotic Compounds. Top assignees: Roussel Uclaf, Hoechst Marion Roussel, Other. Active years: 1991-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Francois Chantot. Retrieved from https://idiyas.com/inventor/jean-francois-chantot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 10

Forward Citations = 357(Granted Patents)


Location History:

  • Gressy, FR (1999)
  • Nogent sur Marne, FR (1995 - 2000)
  • Nogent sur Maine, FR (1997 - 2000)
  • Gressy-en-France, FR (1991 - 2001)

Company Filing History:


Years Active: 1991-2001

Loading Chart...
Areas of Expertise:
Cephalosporins
Erythromycin Derivatives
Erythromycin Compounds
Propanal Derivatives
Pharmaceutical Chemistry
Antibiotic Formulations
Synthetic Methods
Drug Preparation
Biochemical Applications
Medicinal Chemistry
Organic Synthesis
Pharmacology
27 patents (USPTO):Explore Patents

Title: Jean-Francois Chantot: Pioneering Innovations in Pharmaceutical Science

Introduction: Jean-Francois Chantot, a brilliant inventor hailing from Gressy en France, FR, stands as a beacon of innovation, inspiring others with his creative spirit and unwavering commitment to shaping a brighter future through his inventions. With an impressive portfolio of 27 patents, Chantot has made remarkable contributions to the field of pharmaceutical science.

Latest Patents: Among his latest patents is a groundbreaking invention in the realm of pharmaceuticals - Cephalosporins. This compound boasts a formula selected from the group consisting of Erythromycin derivatives, showcasing Chantot's expertise in developing cutting-edge solutions. The patented method for preparing this compound and its various applications highlight his ingenuity and forward-thinking approach.

Career Highlights: Throughout his illustrious career, Jean-Francois Chantot has left an indelible mark on renowned companies such as Roussel Uclaf and Hoechst Marion Roussel, where he spearheaded innovative projects and brought revolutionary ideas to life. His relentless pursuit of excellence and dedication to advancing pharmaceutical science have positioned him as a trailblazer in the industry.

Collaborations: Collaborating with esteemed colleagues such as Jozsef Aszodi and Constantin Agouridas, Chantot has fostered a culture of innovation and shared expertise, leading to the development of groundbreaking solutions that have disrupted the pharmaceutical landscape. His ability to collaborate effectively and leverage collective knowledge underscores his status as a visionary inventor.

Conclusion: Jean-Francois Chantot's exemplary work ethic, coupled with his remarkable talent for innovation, has solidified his reputation as a pioneering force in the field of pharmaceutical science. His unwavering commitment to pushing the boundaries of invention continues to inspire future generations of inventors, paving the way for a brighter and more innovative future in the realm of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…